List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 97 studies with search of: Maraviroc OR Selzentry[TREATMENT] AND HIV
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed
Has Results 		A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients
Condition: Human Immunodeficiency Virus-1
Intervention: Drug: maraviroc
2 Recruiting Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With Ccr5 Tropic HIV 1
Condition: HIV-1
Interventions: Drug: Maraviroc;   Drug: Emtricitabine/tenofovir
3 Not yet recruiting A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Maraviroc
4 Unknown † CCRC: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy
Condition: HIV Infections
Interventions: Drug: maraviroc in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor);   Drug: maraviroc plus raltegravir in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor);   Drug: efavirenz [or other NNRTI (non-nucleoside reverse transcriptase inhibitor)];   Procedure: upper endoscopy procedure
5 Unknown † Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Placebo
6 Recruiting An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Maraviroc
7 Unknown † Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients
Conditions: HIV-1 Adults Patients;   AIDS;   Triple Class Failure
Interventions: Drug: maraviroc;   Drug: Raltegravir;   Drug: Darunavir/ritonavir
8 Completed Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus
Condition: HIV
Interventions: Drug: Maraviroc (UK-427,857);   Other: Placebo
9 Active, not recruiting Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Conditions: Immune Reconstitution Inflammatory Syndrome;   HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: Placebo
10 Active, not recruiting Maraviroc in Immunological Non-Responder (INR) HIV-1-infected Subjects
Condition: HIV Infections
Intervention: Drug: Maraviroc
11 Completed Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
Conditions: HIV Infection;   HIV Infections
Intervention: Drug: maraviroc
12 Not yet recruiting Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients
Condition: HIV Infections
Intervention: Drug: MVC/RAL/FTC/TDF followed by Maraviroc/Raltegravir
13 Completed
Has Results 		Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: Optimized Background Therapy (OBT);   Drug: maraviroc (UK-427,857)
14 Recruiting A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Conditions: HIV Coinfection;   Hepatitis C;   Hepatitis B;   Hepatotoxicity
Interventions: Drug: Maraviroc;   Drug: Placebo
15 Completed
Has Results 		Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: Maraviroc (UK-427,857);   Drug: optimized background therapy
16 Recruiting Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir plus maraviroc
17 Enrolling by invitation Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
Condition: Kaposi's Sarcoma
Intervention: Drug: Maraviroc
18 Unknown † Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
Condition: HIV Infections
Intervention: Drug: maraviroc (Selzentry)
19 Terminated Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens
Condition: HIV Infections
Interventions: Drug: Maraviroc;   Drug: placebo
20 Active, not recruiting Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects
Conditions: HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: control group

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services